Chong Kun Dang Holdings Corp. (001630.KS)

KRW 50100.0

(-0.6%)

Market Cap (In KRW)

238.5 Billion

Revenue (In KRW)

879.78 Billion

Net Income (In KRW)

47 Billion

Avg. Volume

2606.00

Currency
KRW
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
47150.0-64300.0
PE
-
EPS
0.0
Beta Value
0.604
ISIN
KR7001630003
CUSIP
-
CIK
-
Shares
4760557.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Tae Young Kim
Employee Count
-
Website
https://www.ckd-holdings.com/company/summary.do
Ipo Date
2000-01-04
Details
Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. The company was founded in 1941 and is headquartered in Seoul, South Korea.